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When T cells encounter antigens via the T cell antigen
receptor (TCR), information about the quantity and
quality of antigen engagement is relayed to the intra-
cellular signal transduction machinery. This process
is poorly understood. The TCR itself lacks a significant
intracellular domain. Instead, it is associated with CD3
molecules that contain intracellular signaling domains
that couple the TCR/CD3 complex to the downstream
signaling machinery. The earliest events in TCR sig-
naling must involve the transfer of information from
the antigen binding TCR subunit to the CD3 signaling
subunits of the TCR/CD3 complex. Elucidating the
structural organization of the TCR with the associated
CD3 signaling molecules is necessary for understand-
ing the mechanism by which TCR engagement is cou-
pled to activation. Here, we review the current state of
our understanding of the structure and organization of
the TCR/CD3 complex.
Introduction
The TCR is the primary trigger for the clonal expansion
of antigen-specific cells from the T cell repertoire (Davis
et al., 1998). Most T cells express abTCRs, composed of
disulfide-bonded a and b chains, which typically bind
composite surfaces of antigenic peptides presented
by major histocompatibility molecules (pMHC). A small
subset of T cells express gdTCRs composed of disul-
fide-bonded g and d chains. These bind directly to path-
ogen-derived glycoproteins or nonclassical MHC mole-
cules (Adams et al. [2005], Chien et al. [1996], and
references therein). For ab- and gdTCRs, clonotypically
rearranged V, (D), and J gene segments encode the
extracellular Ig fold of the variable domain. A constant
region gene segment encodes the extracellular constant
domain, the connecting peptide, the transmembrane
domain, and a minimal intracellular domain. The con-
stant domains of the b, d, and g chains adopt a standard
Ig fold (Adams et al., 2005; Garcia et al., 1996). The
a chain constant region (Ca) adopts an atypical Ig fold
due to the absence of a top b sheet.
Cell surface expression of the TCR occurs in associa-
tion with, and is dependent upon, the CD3ge, de, and zz
signaling subunits (Brenner et al. [1985], Samelson et al.
[1985], Sussman et al. [1988], Wegener et al. [1995], and
references therein). The extracellular domains of the
CD3de and CD3ge heterodimers consist of side-by-
side paired Ig folds (Figure 1A), whereas those of the
CD3zz homodimer are only nine residues long and are
*Correspondence: kcgarcia@stanford.eduof unknown structure (Arnett et al., 2004; Kjer-Nielsen
et al., 2004; Sun et al., 2001, 2004). In contrast to the
long connecting peptides of the TCR chains (19–26
aa), both CD3 heterodimers have short (5–10 aa) con-
necting peptides. These contain cysteine-rich (RxCxxCxE)
motifs that assist in pairing of the CD3 heterodimer sub-
units and may play a role in signaling (Sun et al. [2001]
and references therein). The intracellular domains of
each of the CD3 chains contain immunoreceptor tyro-
sine-based activation motifs (ITAMs) that serve as the
nucleating point for the intracellular signal transduction
machinery upon TCR engagement (reviewed in Kane
et al. [2000]). The CD3 d, g, and e chains each contain
one ITAM, and CD3z contains three ITAMs.
Depending on one’s focus, either the ligand binding
variable region of the TCR or the signal-initiating ITAMs
of the CD3 molecules may be considered the ‘‘business
end’’ of the TCR/CD3 complex; and much has been
learned about the biophysical and structural properties
of TCR/ligand interactions and the intracellular signaling
events that follow. By comparison, the ‘‘guts’’ of the com-
plex, including the transmembrane domains, the con-
necting peptides, the CD3 Ig domains, and the TCR
constant regions, are poorly understood in terms of their
spatial organization or how they pass information from
one end to the other (Figures 1 and 2).
Transmembrane Interactions and Organization
Highly conserved charged residues in the transmem-
brane helices of the TCR and CD3 chains have long
been considered important for abTCR/CD3 complex as-
sembly (Manolios et al. [1990] and references therein).
Recent efforts to elucidate the rules of these transmem-
brane charge interactions have revealed the precise
stoichiometry of a nascent complex (Call et al., 2002).
The TCR a chain has two basic transmembrane residues
(Figure 1A). One interacts with the acidic transmem-
brane residues of one CD3de heterodimer, and the other
interacts with the acidic transmembrane residues of one
CD3zz homodimer. Their conserved spatial relationship
is critical to their function and provides insight into the
orientation of the transmembrane domains. The TCR
b chain also has a highly conserved basic transmem-
brane residue. It interacts with the acidic residues in
the transmembrane helices of one CD3ge heterodimer,
but the relationship of this charged residue to those of
the TCR a chain in an abTCR heterodimer are unknown.
The composition of a nascent gdTCR/CD3 complex
differs from that of an abTCR/CD3 complex (Figure 1A).
The basic transmembrane residues described for the
abTCR are conserved in the transmembrane domains
of the homologous TCR d and g chains, respectively. Al-
though this may predict an identical subunit composi-
tion to that of the abTCR/CD3 complex, CD3de has
been shown to be absent from the gdTCR/CD3 complex
in spite of the presence of cytoplasmic CD3d (Hayes and
Love, 2002). Instead, two CD3ge subunits associate with
the gdTCR (Hayes and Love, 2006). Interestingly, the
subunit composition of the gdTCR/CD3 complex is
different between naive and activated gdT cells. In
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134Figure 1. TCR/CD3 Complex Subunits and Intersubunit Interaction Sites
(A) The ‘‘anatomy’’ of abTCR/CD3 (left) and gdTCR/CD3 (right) complexes, showing extracellular, transmembrane, and intracellular regions. In-
teracting ionizable transmembrane residues are highlighted, with the acidic residues in the CD3 transmembrane regions colored red and the
basic residues in the TCR transmembrane residues colored blue. The two acidic-one basic electrostatic interactions are depicted in the red
to blue ovals. This figure is modified from the basic concepts presented by Wucherpfennig and colleagues (Call et al., 2002, 2005).
(B) Putative extracellular CD3de and CD3ge docking sites on the abTCR. Surface-rendered models of the 2C TCR are shown with the a chain
primarily in white and the b chain primarily in purple. CD3 docking sites previously proposed in the literature are highlighted as blue (Garcia
et al., 1996), cyan (Garcia et al., 1996; Karaivanova et al., 1999; Kjer-Nielsen et al., 2003; Sun et al., 2004), green (Ghendler et al., 1998; Kjer-Nielsen
et al., 2003; Sun et al., 2001, 2004), and orange (Sun et al., 2001).activated gdT cells, the TCR is found to associate with at
least two different glycosylated forms of CD3ge and
FcRg is incorporated into the complex as a homodimer
or heterodimer with CD3z (Hayes et al., 2002). Thus, the
composition of the CD3 subunits differs between the
ab- and gdTCR/CD3 complexes and between naive
and activated gdT cells (Hayes et al., 2002).
Although the transmembrane charge residues dis-
cussed above are critical to the TCR/CD3 complex,
other transmembrane residues appear to contribute to
the assembly and stability of these complexes. The
TCR b and g chains share highly conserved transmem-
brane tyrosine residues (referenced in Teixeiro et al.
[2004]). When the C-terminal tyrosine is mutated in theb chain, CD3zz associates loosely with the complex.
Also, the TCR b chain contains a highly conserved trans-
membrane glutamic acid that is not found in the g chain
(see figures in Backstrom et al. [1996] and Teixeiro et al.
[2004]). Given the strength and range of interactions that
transmembrane charge residues can mediate (Call and
Wucherpfennig, 2005; Engelman, 2003), it is tempting
to speculate that this residue may be a key determinant
in the differential CD3 composition of the ab and gd com-
plexes.
The data on this acidic transmembrane residue are
mixed. A chimeric TCR/CD3 complex that lacks the
TCR b chain glutamic acid, due to fusion with the trans-
membrane and intracellular domains of the TCR g chain
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135Figure 2. Possible Mechanisms of TCR/CD3 Signal Transduction Involving Extracellular Interactions
An abTCR/CD3 complex, with subunits colored as in Figure 1A, is presented binding a pMHC (gray). The numbered scenarios are fully explained
in the main text. Similar mechanisms can be considered for gdTCR/CD3 complexes. Although the abTCR/CD3 complex is shown in the conven-
tional manner, with the CD3 heterodimers on opposite sides of the TCR, it is equally possible that the CD3 heterodimers are oriented adjacent to
one another within the full TCR/CD3 complex. CD3zz has been omitted, because it lacks a significant extracellular domain, but it must be con-
sidered in future models as more information becomes available regarding the orientation of the extracellular domains of the CD3 heterodimers
and the spatial relationship between the transmembrane ionizable residues and the extracellular domains. These five scenarios do not exhaust
all of the mechanistic possibilities.(bIII), is associated at normal levels with the TCR a chain,
CD3de, CD3e, and CD3zz in total cell lysates of trans-
genic T cells (Teixeiro et al., 2004). This may suggest
that the b chain glutamic acid is not critical to complex
assembly, composition, or stability. However, TCR a
chains fused to different portions of the connecting pep-
tide as well as the transmembrane and intracellular re-
gions of the TCR d chain (called aIII, aIV, and aV) have
impaired cell surface expression when paired with the
TCR b chain or with two distinct TCR b chain chimeras,
which include the transmembrane glutamic acid, fused
to different amounts of the TCR g chain transmembrane
and intracellular domains (called bI and bII) (Backstrom
et al., 1996). Surface expression is restored, however,
when the aIII, aIV, or aV chimeras are paired with the
bIII chimera. The difference between the bII and bIII
chains is five residues, one of which is the glutamic
acid, suggesting that this stretch of transmembrane res-
idues is critical to the assembly and composition of the
chimeric TCR/CD3 complexes. Indeed, CD3zz associ-
ates poorly with the aIII, aIV, or aV/bIII chimeric TCRs.
Furthermore, CD3d appears to be absent from aIIIbIII
and aIVbIII complexes, indicating that this complex
more closely resembles the gdTCR/CD3 complex than
the abTCR/CD3 complex in its subunit composition
(Backstrom et al., 1998; Werlen et al., 2000). Still, it is im-
portant to note that the aIIIbIII and aIVbIII chimera also
differs from abTCRs in the a chain connecting peptide
(Backstrom et al., 1996), and the ab and gd TCRs differ
overall in their extracellular domains (Adams et al.,
2005).
Extracellular Interactions
Considerable evidence exists indicating that the extra-
cellular regions of the CD3 heterodimers interact with
the extracellular regions of the abTCR constant do-
mains; yet for more than 20 years, these contact sites
have remained a mystery. Even less is known about
the gdTCR/CD3 complex. These gaps in our under-standing are likely to reflect the complexity of the inter-
actions that assemble and hold them together, and the
difficulty in studying complexes that are codependent
on multiple subunit interactions. The tight transmem-
brane associations of the abTCR and CD3 heterodimers,
and the short length of the CD3 connecting peptides,
compared with the TCR, indicate that the extracellular
Ig domains of the CD3 heterodimers will be adjacent to
and just below the TCR constant domains (Figure 1A).
Extracellular contacts between these subunits may sim-
ply be coincident to the transmembrane interactions,
like balloons that bump into each other because their
strings are held together in a bunch, with no specificity
whatsoever. However, the existing data suggest that ex-
tracellular interactions are likely to be specific. In addi-
tion, because interactions between soluble forms of
the extracellular regions of the abTCR and CD3 hetero-
dimers have not been observed in solution (Sun et al.,
2001, 2004), the connecting peptides, the transmem-
brane interactions, or the membrane environment itself
may be essential to facilitate extracellular interactions
between the TCR and the CD3 heterodimers.
A motif in the connecting peptide of the TCR a chain
(aCPM) has been implicated in mediating extracellular
interactions with CD3de (Backstrom et al., 1998; Werlen
et al., 2000). However, the transmembrane differences
between abTCRs and the aIIIbIII and aIVbIII complexes
may explain these results, as noted above. In addition,
the aIII chimera has a four amino acid extension in the
connecting peptide, compared with the TCR a chain,
whereas the aIV chimera has a three amino acid deletion
(Backstrom et al., 1996). These differences in length
force an offset in the cysteines that form the interchain
disulfide bond that could lead to changes in the orienta-
tion of the TCR with respect to the membrane. This
could interfere with the docking of CD3de at a more
distal site on the TCR a chain constant region. Although
directed targeting of just the TCR a-CPM does not
impact TCR surface expression, the CD3 composition
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136of these mutant TCR/CD3 complexes was not shown
or discussed (Backstrom et al., 1996). Thus, the as-
signment of TCR/CD3de interactions at the aCPM is
debatable.
Compelling evidence for the existence of specific ex-
tracellular abTCR and CD3 heterodimer contacts comes
from assembly studies showing that the transmembrane
interactions between the abTCR and the CD3 hetero-
dimers do not confer specificity to the association and
assembly of the complex. Swapping the transmem-
brane and intracellular regions of CD3g with CD3d al-
lows normal incorporation of this chimeric CD3g into
a TCR/CD3 complex in cells lacking CD3g expression
(Wegener et al., 1995). In contrast, if CD3d contains the
CD3g transmembrane and intracellular regions, then it
is not incorporated into a TCR/CD3 complex in cells
lacking CD3g, indicating that the composition of CD3
heterodimers in an abTCR/CD3 complex is directed by
the extracellular regions of the subunits rather than the
transmembrane domains. Call et al. also found the
transmembrane domains of CD3g and d to be promiscu-
ous (Call et al., 2002). But, in three chain assembly ex-
periments, they observed that the TCR a chain primarily
interacts with CD3de over CD3ge. This indicates that ex-
tracellular interactions must confer specificity to TCR
a chain interactions with CD3de over CD3ge.
The story regarding extracellular abTCR/CD3ge inter-
actions is less straight forward but more intriguing. The
TCR b chain interacts similarly with CD3de and CD3ge in
three chain assembly experiments (Call et al., 2002). This
may indicate an absence of extracellular interactions
between the TCR b chain and the CD3 heterodimers or
that extracellular interactions only occur via CD3e. The
latter possibility is supported by a report that the TCR
b chain interacts with CD3d, g, and e but that only the in-
teractions with CD3e require the extracellular domains
(Manolios et al., 1994). However, this predicts that an
abTCR/CD3 complex could contain either two CD3de
heterodimers or one CD3de and one CD3ge heterodimer,
and Call et al. clearly showed that only one CD3de and
one CD3ge incorporate into the full complex (Call et al.,
2002). Indeed, only one CD3de interacts with the full
abTCR in the absence of any other chains. Although
this TCR/CD3de interaction is not impacted by the pres-
ence or absence of the CD3ge heterodimer, the associ-
ation of CD3ge with the abTCR heterodimer is severely
reduced by the absence of CD3de. Only a quarter of
the amount of CD3ge that interacts with the abTCR in
the presence of CD3de is found associated with the
abTCR in the absence of CD3de. Thus, CD3de associa-
tion with the abTCR heterodimer enables CD3ge to sub-
sequently associate at normal levels.
Several mechanisms could explain the CD3de depen-
dency of CD3ge association with the abTCR. One could
involve interactions of the transmembrane charge resi-
dues, given the unique interactions that may occur
within the membrane environment during complex as-
sembly. Alternatively, an extracellular docking site for
CD3ge might be formed by contributions from the TCR
and CD3de. The extracellular region of the CD3g chain
is likely to interact with the TCR b chain, as these chains
can be chemically crosslinked (Brenner et al., 1985).
Also, CD3d and CD3g might form extracellular interac-
tions within the complex, as Klausner and colleaguespreviously found these chains can weakly interact
when coexpressed in COS cells (Manolios et al., 1991).
Interestingly, removing the transmembrane charge resi-
dues increases this CD3d/g interaction (Manolios et al.,
1991), eliminating the possibility that their transmem-
brane acidic charges mediate oligomerization (refer-
enced in Call and Wucherpfennig [2005]), whereas the
concomitant expression of CD3e prevents the interac-
tion. Thus, a coordinated combination of transmem-
brane and extracellular interactions may mediate the
specific assembly, composition, and stability of abTCR/
CD3 complexes, as the scenarios outlined above are not
mutually exclusive.
Extracellular Organization
The spatial organization of the extracellular domains of
the ab- and gdTCR/CD3 complexes will depend on the
extracellular contacts between the subunits, which are
currently unknown. Nevertheless, antibody-mapping
studies, structural analysis, and charge complemen-
tarity studies have been used for modeling abTCR/
CD3-docking sites. The CD3 heterodimer docking sites
proposed for the abTCR are summarized below and
highlighted in Figure 1B.
One model of extracellular abTCR/CD3 organization
places the CD3 heterodimers on opposite sides of the
TCR. This is discussed and illustrated in greater detail
by Sun et al. (2004). In brief, CD3ge is thought to interact
with a pocket on the TCR b chain that is bordered by the
b chain constant region (Cb) FG loop and contains the
Ca AB loop. This stems from the finding that prestaining
T cells with monoclonal antibody (mAb) H57, which
binds the Cb FG loop, reduces the subsequent staining
with mAb 2C11, which binds an unknown epitope on
CD3e (Ghendler et al., 1998). Thus, H57 is thought to ste-
rically hinder 2C11 binding to one of the CD3e chains,
which implies a close proximity between the Cb FG
loop and one of the CD3e molecules. The complemen-
tarity of this net positive pocket, including a basic
charge in the Ca AB loop, with the net negative charge
of CD3e, also supports this hypothesis (Ghendler et al.,
1998; Kjer-Nielsen et al., 2003). CD3ge is thought to be
the heterodimer that resides in this pocket due to the
transmembrane pairing and the ability to crosslink
CD3g to the TCR b chain (Brenner et al., 1985), whereas
the transmembrane pairing of CD3de with the TCR
a chain is thought to place it on the opposite side of
the TCR. The CD3 heterodimers are thought to contact
the TCR in an open face manner that maximizes subunit
contact. This is consistent with the findings that the TCR
b chain interacts with CD3e in an extracellular domain-
dependent manner (Manolios et al., 1994) and with the
b-chain/CD3g crosslinking data.
Alternative docking sites have also been proposed.
The top strands of the Ca domain are unusually flexible
and could serve as a binding site for a CD3 heterodimer
(Figure 1B, cyan and blue) (Garcia et al., 1996). Also, an
acidic pocket in the human TCR Ca has been proposed
as a docking site for the highly basic CD3g chain of a
CD3ge heterodimer (Kjer-Nielsen et al., 2002). The corre-
spondence of this pocket with the region of the mouse
TCR recognized by the mAb H28 (Figure 1B, cyan) (Kar-
aivanova et al., 1999), which only binds the mouse TCR
in the absence of the CD3 heterodimers, is considered
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ing site (Kjer-Nielsen et al., 2002). However, it appears to
overlap with the CD3de docking site proposed by Sun
et al. (2004), thus either CD3 heterodimer might interact
at this site. In addition, a docking site for CD3e has been
proposed based on in silico molecular docking that in-
cludes the exposed surface of the Cb GFCC0 face
(Figure 1B, orange) (Sun et al., 2001). Given the variety
of putative docking sites proposed in the literature,
and highlighted in Figure 1B, it is evident that the
CD3 heterodimers might interact with the TCR almost
anywhere. It is even possible that they could contact
one another when contacting the TCR. This would be
consistent with the findings from Call et al. that TCR/
CD3de association enables optimal TCR/CD3ge interac-
tions, particularly if TCR/CD3de interactions lead to the
formation of an optimal docking site for the CD3g chain
of the CD3ge heterodimer (Call et al., 2002). Structural or
direct biochemical data will be required to formally iden-
tify the CD3 heterodimer docking sites and elucidate the
organization of the extracellular domains of the complex
subunits.
TCR/CD3 Interactions and Signal Transduction
The ultimate goal of understanding the TCR/CD3 sub-
unit interactions and organization is to understand the
earliest events of TCR signaling. The nature of these
multisubunit transmembrane receptors makes deter-
mining the overall structures of these complexes in li-
ganded and unliganded states a significant technical
challenge. Visualizing these structures at a resolution
that could reveal the slight conformational shifts be-
tween the extracellular, transmembrane, and/or intra-
cellular domains of the subunits that may occur during
signaling is even more daunting. Likewise, using molec-
ular and biochemical techniques to deconstruct the or-
ganizational and signaling mechanism is challenging be-
cause components that are key to signaling may also be
critical for complex assembly and surface expression.
Thus, disrupting these contacts to study their function
might be precluded by a decrease in, or lack of, TCR ex-
pression—such as in the transmembrane charge inter-
actions. In turn, disrupting one of several weak extracel-
lular interactions might allow for normal TCR expression
and comparable functional studies with wild-type TCRs,
but the impact on TCR signaling may read out as subtle
modulations rather than a major impairment of signaling.
In spite of these hurdles, models of the earliest events of
TCR/CD3 signaling need to be considered and tested.
Several mechanisms can be imagined for how infor-
mation is transferred from the ligand binding interface
to the ITAMs. Within the transmembrane regions, strong
electrostatic interactions between the complex subunits
might serve as pivot points whereby the helices can
slide with respect to one another (Engelman, 2003). As
discussed in detail elsewhere, conformational changes
in the intracellular domains of the CD3 subunits have
been observed, which are likely to be the earliest mani-
festation of transmembrane movements (Gil et al., 2002,
2005). The force to mediate such movements is certain
to derive from the extracellular domains of the TCR
and, possibly, the CD3 heterodimers. Figure 2 depicts
five separate scenarios of how movements within the
extracellular domains of a TCR/CD3 complex could me-diate signal transduction upon TCR engagement. Al-
though each of these models have fundamental dif-
ferences, they uniformly converge on the idea that
somehow ligand engagement of the TCR results in a per-
turbation of the extracellular region of the TCR/CD3
complex through either a rigid body or intermolecular
conformational change.
In the first scenario, TCR engagement induces a con-
formational change in the TCR. CD3 heterodimers inter-
acting loosely with the TCR shift their orientation with re-
spect to the TCR to accommodate the conformational
change. In the second scenario, the CD3 heterodimers
have strong extracellular interactions with the TCR that
cause them to move when the TCR undergoes a confor-
mational change upon ligand engagement. Both scenar-
ios are unlikely for abTCR/CD3 complexes, as a global
conformation change in the extracellular regions of the
known abTCR structures has not been observed in the
bound versus unbound state. Still, TCR engagement
may cause a local conformational change in the TCR
Ca domain, as has been observed in the Ca AB loop in
one study (Kjer-Nielsen et al., 2003), which could change
the orientation of at least one of the CD3 heterodimers
with respect to the TCR and/or the membrane. Insuffi-
cient data exist to rule out these scenarios for the
gdTCR/CD3 complexes.
The third scenario depicts a change in the orientation
of the TCR with respect to the membrane that also
changes itsorientation to looselyassociatedCD3hetero-
dimers. Torque generated as the TCR CDR3 loops un-
dergo conformational changes to optimally contact the
peptide may also be transmitted through the TCR
(Krogsgaard et al., 2003), causing further reorientation
of the TCR and loosely associated CD3 heterodimers.
The last two scenarios represent mechanisms for sig-
naling by tightly associated TCR/CD3 complexes that
move in unison as a rigid signal transduction module.
In scenario four, TCR engagement is envisioned to dis-
place the CD3 heterodimers into the membrane in a ‘‘pis-
ton-like’’ movement (Sun et al., 2001). A twist on this
model could come from torque generated by CDR3
movements, as in scenario three, resulting in a signaling
mechanism that resembles the motion required to open
a child-proof safety cap (Krogsgaard et al., 2003). For
scenario five, binding would cause the TCR to adopt
a change in orientation with respect to the membrane.
The CD3 heterodimer positioned between the TCR and
the membrane would be displaced into the membrane
as the angle between the TCR and membrane is dimin-
ished, whereas the CD3 heterodimer on the opposite
side would be pulled away from the membrane. If the
CD3 heterodimers are actually adjacent to one another
in the complex, then both may be pushed or pulled de-
pending on the location of their association with the
TCR.
Multimerization into dimers or higher order species is
also a common signaling model envisioned for abTCR/
CD3 complexes (Davis et al., 1998). Although not de-
picted in Figure 2, changes in the orientation of the com-
plex subunits with respect to each other or the mem-
brane may lead to the exposure or formation of an
optimal multimerization interface. The use of soluble
peptide-MHC dimers has clearly shown that this minimal
unit can activate abT cells, even when the constituents
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(Krogsgaard et al., 2005). The structure of a gdTCR
bound to its cognate ligand reveals a TCR/ligand dimer
that may have functional significance (Adams et al.,
2005), suggesting that TCR multimerization may also
be important for the activation of this cell type.
In closing, TCR/CD3 signaling is central to the initia-
tion of antigen-specific T cell responses to pathogens
and vaccines, as well as transplanted tissues, tumors,
and autoantigens. Elucidating the earliest events in T
cell signaling is critical to building our basic knowledge
of these responses and to advancing efforts to enhance
or attenuate T cell responses in vivo. For example, mAbs
specific for human CD3e have been used or tested as
immunomodulating agents in preventing transplant re-
jection and in the treatment of autoimmune diseases
(Chatenoud [2005], Kjer-Nielsen et al. [2004], and refer-
ences therein). The crystal structure of the Fab fragment
of the therapeutic anti-hCD3e mAb OKT3 has been
solved in complex with hCD3ge (Kjer-Nielsen et al.,
2004). In this complex, the authors speculate that
OKT3 would ‘‘dislodge’’ CD3e from the TCR. However,
because we do not know the orientation of the CD3 het-
erodimers bound to the TCR, this model remains un-
proven. Determining the overall structure of the complex
is needed to better understand the mechanism of action
of this therapeutic agent, and for the development of
new agents and strategies.
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